Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0000950170-25-038801

Chief Executive Officer acquired 350,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Barrow Robert Chief Executive Officer 2025-03-12 Grant or award +350,000 877,764 D
Loading xslF345X05/ownership.xml…